These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32376036)

  • 21. One-year efficacy and safety of rosuvastatin + fenofibric acid combination therapy in patients with mixed dyslipidemia: evaluation of dose response.
    Ferdinand KC; Davidson MH; Kelly MT; Setze CM
    Am J Cardiovasc Drugs; 2012 Apr; 12(2):117-25. PubMed ID: 22263674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-Term Safety of a Novel Angiotensin Receptor Blocker, Fimasartan, According to the Absence or Presence of Underlying Liver Disease in Korean Hypertensive Patients: A Prospective, 12-Month, Observational Study.
    Oh GC; Joo KW; Kim MA; Choi DJ; Kim YJ; Lee HY
    Drug Des Devel Ther; 2020; 14():1341-1349. PubMed ID: 32308367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of rosuvastatin 5 mg in combination with fenofibric acid 135 mg in patients with mixed dyslipidemia - a phase 3 study.
    Roth EM; Rosenson RS; Carlson DM; Fukumoto SM; Setze CM; Blasetto JW; Khurmi NS; Stolzenbach JC; Williams LA
    Cardiovasc Drugs Ther; 2010 Dec; 24(5-6):421-8. PubMed ID: 20953684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy.
    Yan X; Li Y; Dong Y; Wu Y; Li J; Bian R; Hu D
    Lipids Health Dis; 2019 Jan; 18(1):32. PubMed ID: 30696435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and the Tolerability of a Triple Combination of Amlodipine/Losartan/Rosuvastatin in Patients With Comorbid Essential Hypertension and Hyperlipidemia.
    Lee HY; Kim SY; Choi KJ; Yoo BS; Cha DH; Jung HO; Ryu DR; Choi JH; Lee KJ; Park TH; Oh JH; Kim SM; Choi JY; Kim KH; Shim J; Kim WS; Choi SW; Park DG; Song PS; Hong TJ; Rhee MY; Rha SW; Park SW
    Clin Ther; 2017 Dec; 39(12):2366-2379. PubMed ID: 29150250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholesterol goal attainment in hypertensive patients: the impact of metabolic syndrome components.
    Rodrigues CJ; Ribeiro HF; Ribeiro AB; Zanella MT; Batista MC
    Metab Syndr Relat Disord; 2012 Jun; 10(3):195-201. PubMed ID: 22313142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fimasartan versus perindopril with and without diuretics in the treatment of elderly patients with essential hypertension (Fimasartan in the Senior Subjects (FITNESS)): study protocol for a randomized controlled trial.
    Kang MG; Kim KI; Ihm SH; Rhee MY; Sohn IS; Lee HY; Park S; Jeon ES; Song JM; Pyun WB; Sung KC; Kim MH; Kim SH; Kim SY; Kim SJ; Kim EJ; Shin J; Lee SY; Chun KJ; Jeong JO; Chae SC; Yoo KD; Choi YJ; Park YH; Kim CH
    Trials; 2019 Jul; 20(1):389. PubMed ID: 31262348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PK/PD evaluation of fimasartan for the treatment of hypertension Current evidences and future perspectives.
    Angeli F; Verdecchia P; Trapasso M; Pane M; Signorotti S; Reboldi G
    Expert Opin Drug Metab Toxicol; 2018 May; 14(5):533-541. PubMed ID: 29676941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Compared with atorvastatin at the dose of 10 mg per day rosuvastatin was more effective to reach an LDL goal of < 1.00 g/l in high cardiovascular risk patients (ARIANE study)].
    Danchin N; Chadarevian R; Gayet JL; Licour M; Valensi P
    Ann Cardiol Angeiol (Paris); 2007 Apr; 56(2):82-7. PubMed ID: 17484092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and hypertension.
    Kim W; Chang K; Cho EJ; Ahn JC; Yu CW; Cho KI; Kim YJ; Kang DH; Kim SY; Lee SH; Kim U; Kim SJ; Ahn YK; Lee CH; Shin JH; Kim M; Park CG
    J Clin Hypertens (Greenwich); 2020 Feb; 22(2):261-269. PubMed ID: 32003938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combining rosuvastatin with angiotensin-receptor blockers of different PPARγ-activating capacity: effects on high-density lipoprotein subfractions and associated enzymes.
    Rizos CV; Liberopoulos EN; Tellis K; DiNicolantonio JJ; Tselepis AD; Elisaf MS
    Angiology; 2015 Jan; 66(1):36-42. PubMed ID: 24288364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attainment of goal/desirable lipid levels in patients with mixed dyslipidemia after 12 weeks of treatment with fenofibric acid and rosuvastatin combination therapy: a pooled analysis of controlled studies.
    Roth EM; Rosenson RS; Jones PH; Davidson MH; Kelly MT; Setze CM; Lele A; Thakker K
    J Clin Lipidol; 2012; 6(6):534-44. PubMed ID: 23312049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: a phase 3 study.
    Jones PH; Davidson MH; Kashyap ML; Kelly MT; Buttler SM; Setze CM; Sleep DJ; Stolzenbach JC
    Atherosclerosis; 2009 May; 204(1):208-15. PubMed ID: 18996523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. I-ADD study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with irbesartan monotherapy in hypertensive patients uncontrolled with irbesartan 150 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study.
    Bobrie G;
    Clin Ther; 2012 Aug; 34(8):1720-34.e3. PubMed ID: 22853847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinic and Home Blood Pressure Lowering Effect of an Angiotensin Receptor Blocker, Fimasartan, in Postmenopausal Women with Hypertension.
    Kim SY; Joo SJ; Shin MS; Kim C; Cho EJ; Sung KC; Kang SM; Kim DS; Lee SH; Hwang KK; Park JB
    Medicine (Baltimore); 2016 May; 95(22):e3764. PubMed ID: 27258507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong).
    Park JS; Shin JH; Hong TJ; Seo HS; Shim WJ; Baek SH; Jeong JO; Ahn Y; Kang WC; Kim YH; Kim SH; Hyon MS; Choi DH; Nam CW; Park TH; Lee SC; Kim HS
    Drug Des Devel Ther; 2016; 10():2599-609. PubMed ID: 27574399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.
    Yusuf S; Lonn E; Pais P; Bosch J; López-Jaramillo P; Zhu J; Xavier D; Avezum A; Leiter LA; Piegas LS; Parkhomenko A; Keltai M; Keltai K; Sliwa K; Chazova I; Peters RJ; Held C; Yusoff K; Lewis BS; Jansky P; Khunti K; Toff WD; Reid CM; Varigos J; Accini JL; McKelvie R; Pogue J; Jung H; Liu L; Diaz R; Dans A; Dagenais G;
    N Engl J Med; 2016 May; 374(21):2032-43. PubMed ID: 27039945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of manidipine plus rosuvastatin versus olmesartan plus rosuvastatin on markers of insulin resistance in patients with impaired fasting glucose, hypertension, and mixed dyslipidemia.
    Liberopoulos EN; Moutzouri E; Rizos CV; Barkas F; Liamis G; Elisaf MS
    J Cardiovasc Pharmacol Ther; 2013 Mar; 18(2):113-8. PubMed ID: 23113965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fimasartan: A New Angiotensin Receptor Blocker.
    Lee HY; Oh BH
    Drugs; 2016 Jul; 76(10):1015-22. PubMed ID: 27272555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic drug interaction study using fimasartan and rosuvastatin in healthy volunteers.
    Kang WY; Kim EH; Seong SJ; Gwon MR; Yang DH; Kim HJ; Lim MS; Lee HW; Yoon YR
    Int J Clin Pharmacol Ther; 2016 Dec; 54(12):992-1003. PubMed ID: 27668695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.